Abionyx manufactures a new batch of ApoA-I CER-001
The vital second batch represents a critical step on the candidate’s pathway to regulatory approval
Read More
Tag: cer-001
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
